198 related articles for article (PubMed ID: 1592468)
1. Role of tissue renin in the pathophysiology of hypertension in TGR(mREN2)27 rats.
Bader M; Zhao Y; Sander M; Lee MA; Bachmann J; Böhm M; Djavidani B; Peters J; Mullins JJ; Ganten D
Hypertension; 1992 Jun; 19(6 Pt 2):681-6. PubMed ID: 1592468
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin II receptor blockade in TGR(mREN2)27: effects of renin-angiotensin-system gene expression and cardiovascular functions.
Böhm M; Lee M; Kreutz R; Kim S; Schinke M; Djavidani B; Wagner J; Kaling M; Wienen W; Bader M
J Hypertens; 1995 Aug; 13(8):891-9. PubMed ID: 8557967
[TBL] [Abstract][Full Text] [Related]
3. Differential development of early hypertension in heterozygous transgenic TGR(mREN2)27 rats.
Kreutz R; Fernandez-Alfonso MS; Paul M; Peters J
Clin Exp Hypertens; 1998 Apr; 20(3):273-82. PubMed ID: 9605382
[TBL] [Abstract][Full Text] [Related]
4. Increased pressor function of central vasopressinergic system in hypertensive renin transgenic rats.
Szczepańska-Sadowska E; Paczwa P; Loń S; Ganten D
J Hypertens; 1998 Oct; 16(10):1505-14. PubMed ID: 9814623
[TBL] [Abstract][Full Text] [Related]
5. Effects of captopril, losartan, and nifedipine on cell hypertrophy of cultured vascular smooth muscle from hypertensive Ren-2 transgenic rats.
Peiró C; Llergo JL; Angulo J; López-Novoa JM; Rodríguez-López A; Rodríguez-Mañas L; Sánchez-Ferrer CF
Br J Pharmacol; 1997 Aug; 121(7):1438-44. PubMed ID: 9257925
[TBL] [Abstract][Full Text] [Related]
6. Role of the circulating renin-angiotensin system in the pathogenesis of hypertension in transgenic rats. TGR(mREN2)27.
Peters J; Hilgers KF; Maser-Gluth C; Kreutz R
Clin Exp Hypertens; 1996 Oct; 18(7):933-48. PubMed ID: 8886477
[TBL] [Abstract][Full Text] [Related]
7. The hypertensive Ren-2 transgenic rat TGR (mREN2)27 in hypertension research. Characteristics and functional aspects.
Langheinrich M; Lee MA; Böhm M; Pinto YM; Ganten D; Paul M
Am J Hypertens; 1996 May; 9(5):506-12. PubMed ID: 8735183
[TBL] [Abstract][Full Text] [Related]
8. Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
Schnecko A; Witte K; Lemmer B
J Cardiovasc Pharmacol; 1995 Aug; 26(2):214-21. PubMed ID: 7475045
[TBL] [Abstract][Full Text] [Related]
9. Contribution of local renin-angiotensin system to cardiac hypertrophy, phenotypic modulation, and remodeling in TGR (mRen2)27 transgenic rats.
Ohta K; Kim S; Wanibuchi H; Ganten D; Iwao H
Circulation; 1996 Aug; 94(4):785-91. PubMed ID: 8772703
[TBL] [Abstract][Full Text] [Related]
10. Progression of renal failure after subtotal nephrectomy in transgenic rats carrying an additional renin gene [TGR(mREN2)27].
Wagner J; Klotz S; Haufe CC; Danser JA; Amann K; Ganten D; Ritz E
J Hypertens; 1997 Apr; 15(4):441-9. PubMed ID: 9211179
[TBL] [Abstract][Full Text] [Related]
11. Roles of AT1 and AT2 receptors in the hypertensive Ren-2 gene transgenic rat kidney.
Zhuo J; Ohishi M; Mendelsohn FA
Hypertension; 1999 Jan; 33(1 Pt 2):347-53. PubMed ID: 9931128
[TBL] [Abstract][Full Text] [Related]
12. Adrenal renin expression and its role in ren-2 transgenic rats TGR(mREN2)27.
Peters J; Ganten D
Horm Metab Res; 1998; 30(6-7):350-4. PubMed ID: 9694562
[TBL] [Abstract][Full Text] [Related]
13. Cardiovascular and renal effects of cyclooxygenase inhibition in transgenic rats harboring mouse renin-2 gene (TGR[mREN2]27).
Cheng ZJ; Finckenberg P; Louhelainen M; Merasto S; Tikkanen I; Vapaatalo H; Mervaala EM
Eur J Pharmacol; 2003 Feb; 461(2-3):159-69. PubMed ID: 12586211
[TBL] [Abstract][Full Text] [Related]
14. The renin-angiotensin system and renal function in transgenic (mRen2)27 rats.
Gross V; Lippoldt A; Bohlender J; Ganten D; Ganten U; Luft FC
Exp Nephrol; 1996; 4 Suppl 1():20-6. PubMed ID: 9001893
[TBL] [Abstract][Full Text] [Related]
15. Regulation of aldosterone biosynthesis by adrenal renin is mediated through AT1 receptors in renin transgenic rats.
Volpe M; Rubattu S; Gigante B; Ganten D; Porcellini A; Russo R; Romano M; Enea I; Lee MA; Trimarco B
Circ Res; 1995 Jul; 77(1):73-9. PubMed ID: 7788884
[TBL] [Abstract][Full Text] [Related]
16. Blockade of angiotensin II type 1 receptor and not of endothelin receptor prevents hypertension and cardiovascular disease in transgenic (mREN2)27 rats via adrenocortical steroid-independent mechanisms.
Rossi GP; Sacchetto A; Rizzoni D; Bova S; Porteri E; Mazzocchi G; Belloni AS; Bahcelioglu M; Nussdorfer GG; Pessina AC
Arterioscler Thromb Vasc Biol; 2000 Apr; 20(4):949-56. PubMed ID: 10764658
[TBL] [Abstract][Full Text] [Related]
17. Increased adrenal renin in transgenic hypertensive rats, TGR(mREN2)27, and its regulation by cAMP, angiotensin II, and calcium.
Peters J; Münter K; Bader M; Hackenthal E; Mullins JJ; Ganten D
J Clin Invest; 1993 Mar; 91(3):742-7. PubMed ID: 8383701
[TBL] [Abstract][Full Text] [Related]
18. Physiological characterization of the hypertensive transgenic rat TGR(mREN2)27.
Lee MA; Böhm M; Paul M; Bader M; Ganten U; Ganten D
Am J Physiol; 1996 Jun; 270(6 Pt 1):E919-29. PubMed ID: 8764174
[TBL] [Abstract][Full Text] [Related]
19. Development of inverse circadian blood pressure pattern in transgenic hypertensive TGR(mREN2)27 rats.
Witte K; Lemmer B
Chronobiol Int; 1999 May; 16(3):293-303. PubMed ID: 10373099
[TBL] [Abstract][Full Text] [Related]
20. Transgenic rats carrying the mouse renin gene--morphological characterization of a low-renin hypertension model.
Bachmann S; Peters J; Engler E; Ganten D; Mullins J
Kidney Int; 1992 Jan; 41(1):24-36. PubMed ID: 1593860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
